AskTheDate.com
Back to calendar

BioMarin Pharmaceutical Inc. (BMRN) Earnings

BMRN reports earnings on Thursday, August 6, 2026

earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $0.95
Actual EPS: $0.76
EPS surprise: 9.81%
Company overview
Market Cap$11.6B
PriceUSD 59.99
P/E43.78
EPS (TTM)1.37
52-week high66.28
52-week low49.26
SectorHealth Technology
IndustryBiotechnology
Employees3,221